CN101939026A - 抗菌联合治疗 - Google Patents

抗菌联合治疗 Download PDF

Info

Publication number
CN101939026A
CN101939026A CN200880025459XA CN200880025459A CN101939026A CN 101939026 A CN101939026 A CN 101939026A CN 200880025459X A CN200880025459X A CN 200880025459XA CN 200880025459 A CN200880025459 A CN 200880025459A CN 101939026 A CN101939026 A CN 101939026A
Authority
CN
China
Prior art keywords
phenyl
group
imidazoles
substituted
disulfiram
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200880025459XA
Other languages
English (en)
Chinese (zh)
Inventor
马尔科姆·菲利普·扬
凯瑟琳·玛莉·托马斯
奥卢索拉·克莱门特·伊多武
朱莉·安妮·查尔顿
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
THERAPEUTICS PLC E
Original Assignee
THERAPEUTICS PLC E
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by THERAPEUTICS PLC E filed Critical THERAPEUTICS PLC E
Publication of CN101939026A publication Critical patent/CN101939026A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN200880025459XA 2007-07-20 2008-07-18 抗菌联合治疗 Pending CN101939026A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0714226.8 2007-07-20
GBGB0714226.8A GB0714226D0 (en) 2007-07-20 2007-07-20 anti-bacterial combination therapy
US96780107P 2007-09-07 2007-09-07
US60/967,801 2007-09-07
PCT/GB2008/002499 WO2009013480A2 (en) 2007-07-20 2008-07-18 Antibacterial combination therapy

Publications (1)

Publication Number Publication Date
CN101939026A true CN101939026A (zh) 2011-01-05

Family

ID=38476732

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200880025459XA Pending CN101939026A (zh) 2007-07-20 2008-07-18 抗菌联合治疗

Country Status (9)

Country Link
US (1) US20110039906A1 (https=)
EP (3) EP2180900A2 (https=)
JP (1) JP2010534199A (https=)
CN (1) CN101939026A (https=)
AU (1) AU2008278827A1 (https=)
CA (1) CA2693544A1 (https=)
GB (1) GB0714226D0 (https=)
WO (1) WO2009013480A2 (https=)
ZA (1) ZA201000919B (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107184581A (zh) * 2017-06-02 2017-09-22 郑州大学 胺基二硫代甲酸盐衍生物在抗菌领域的应用
WO2022257105A1 (en) * 2021-06-11 2022-12-15 The Hong Kong Polytechnic University Methods for treating bacterial cell populations

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100144626A1 (en) * 2006-11-16 2010-06-10 Malcolm Philip Young Treatment of Multi-Drug Resistant Bacterial Infections
GB0724996D0 (en) * 2007-12-21 2008-01-30 Therapeutics Ltd E Antibacterial combination therapy for the treatment of gram positive bacterial infections
GB0813211D0 (en) 2008-07-18 2008-08-27 E Therapeutics Plc Antibacterial combination therapy for the treatment of gram positive bacterial infections
BRPI0904249B1 (pt) * 2009-08-28 2018-03-06 Biolab Sanus Farmacêutica Ltda. Compostos éteres aralquil benzílicos, processo de preparação dos mesmos, uso dos referidos compostos, composição farmacêutica

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB148124A (en) 1915-12-20 1921-09-08 Valerius Smeu Improvements relating to apparatus for dissolving materials in or impregnating them with acids or the like
GB149428A (en) 1919-05-13 1920-08-13 James William Mcmyn Improvements relating to the application of dye stuffs containing the sulphonamide group to dyeing and printing
US3249109A (en) * 1963-11-01 1966-05-03 Maeth Harry Topical dressing
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US4144317A (en) * 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4262003A (en) 1975-12-08 1981-04-14 Alza Corporation Method and therapeutic system for administering scopolamine transdermally
US4307717A (en) 1977-11-07 1981-12-29 Lectec Corporation Sterile improved bandage containing a medicament
NZ210840A (en) * 1984-01-18 1987-05-29 Johnson & Johnson Baby Prod Composition comprising synergistic combination of miconazole nitrate and zinc oxide
US4725439A (en) 1984-06-29 1988-02-16 Alza Corporation Transdermal drug delivery device
FR2843302B1 (fr) * 2002-08-09 2004-10-22 Centre Nat Rech Scient Forme galenique pour la delivrance colique de principes actifs
US20040157837A1 (en) * 2002-11-07 2004-08-12 Serbedzija George N. Combinations for the treatment of fungal infections
US20100144626A1 (en) * 2006-11-16 2010-06-10 Malcolm Philip Young Treatment of Multi-Drug Resistant Bacterial Infections
GB0813211D0 (en) * 2008-07-18 2008-08-27 E Therapeutics Plc Antibacterial combination therapy for the treatment of gram positive bacterial infections

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107184581A (zh) * 2017-06-02 2017-09-22 郑州大学 胺基二硫代甲酸盐衍生物在抗菌领域的应用
WO2022257105A1 (en) * 2021-06-11 2022-12-15 The Hong Kong Polytechnic University Methods for treating bacterial cell populations

Also Published As

Publication number Publication date
WO2009013480A2 (en) 2009-01-29
EP2529733A1 (en) 2012-12-05
AU2008278827A1 (en) 2009-01-29
JP2010534199A (ja) 2010-11-04
CA2693544A1 (en) 2009-01-29
EP2529737A1 (en) 2012-12-05
GB0714226D0 (en) 2007-08-29
EP2180900A2 (en) 2010-05-05
US20110039906A1 (en) 2011-02-17
ZA201000919B (en) 2012-02-29
WO2009013480A3 (en) 2009-06-25
WO2009013480A8 (en) 2010-04-08

Similar Documents

Publication Publication Date Title
CN102112125B (zh) 组合物在制备药物中的用途
RU2628539C2 (ru) Антимикробные составы широкого спектра действия на основе сочетания тауролидина и протамина, а также медицинские устройства, содержащие такие составы
CZ2005820A3 (cs) Antiseptické prostředky, způsoby a systémy
CN101939026A (zh) 抗菌联合治疗
US20220087990A1 (en) Application of rifamycin-quinolizidone conjugate molecule and pharmaceutically acceptable salt thereof
O'Reilly et al. Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin
US20140031275A1 (en) Methods of eradicating bacterial cell populations
EP2094358B1 (en) Imidazoles for treating multi-drug resistant bacterial infections
EP2600927B1 (en) Antimicrobial hydrochloric acid catheter lock solution and method of use
WO2009081117A1 (en) Antibacterial combination therapy for the treatment of gram positive bacterial infections
WO2008059261A1 (en) Clotrimazol for treating staphylococcal infections
WO2023237629A1 (en) N-alkyl-2-substituted atp analogues for use as antibacterial agent

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20110105